naproxen oral suspension
Generic: naproxen oral
Labeler: ani pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
naproxen oral suspension
Generic Name
naproxen oral
Labeler
ani pharmaceuticals, inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
naproxen 125 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
70954-151
Product ID
70954-151_1aa670cb-8d65-413a-9bdd-680cafd9b5c4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211910
Listing Expiration
2026-12-31
Marketing Start
2021-03-12
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70954151
Hyphenated Format
70954-151
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen oral suspension (source: ndc)
Generic Name
naproxen oral (source: ndc)
Application Number
ANDA211910 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 125 mg/5mL
Packaging
- 500 mL in 1 BOTTLE (70954-151-10)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1aa670cb-8d65-413a-9bdd-680cafd9b5c4", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0370954151104"], "unii": ["57Y76R9ATQ"], "rxcui": ["311913"], "spl_set_id": ["252726a7-757a-4b97-b5b8-ffff4ac1d103"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 mL in 1 BOTTLE (70954-151-10)", "package_ndc": "70954-151-10", "marketing_start_date": "20210312"}], "brand_name": "Naproxen Oral Suspension", "product_id": "70954-151_1aa670cb-8d65-413a-9bdd-680cafd9b5c4", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "70954-151", "generic_name": "Naproxen oral", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naproxen Oral Suspension", "active_ingredients": [{"name": "NAPROXEN", "strength": "125 mg/5mL"}], "application_number": "ANDA211910", "marketing_category": "ANDA", "marketing_start_date": "20210312", "listing_expiration_date": "20261231"}